New VA Research Reveals the Far-Reaching Benefits of GLP-1 Medicines

GLP-1 medications have transformed how people manage weight, energy, and long-term health. And according to new research from the U.S. Department of Veterans Affairs and Washington University School of Medicine, their impact may extend even further than expected.

A closer look at the study

Researchers reviewed the medical records of more than two million Veterans using GLP-1 therapies for type 2 diabetes, comparing outcomes across 175 areas of health — from the heart and kidneys to the brain and immune system.

The results showed something remarkable: these medicines appear to support multiple systems at once, not just metabolism.

Highlights from the findings

• Heart and kidney protection. Veterans taking GLP-1s had lower rates of heart disease and kidney complications over time.

• Cognitive and neurological health. Data hinted at reduced risk for conditions like dementia and Alzheimer’s — early but encouraging signs.

• Broader metabolic balance. Fewer inflammatory and infectious conditions were observed, suggesting GLP-1s may help the body find a healthier baseline overall.